Answers are grounded in this paper and cite their sources.
High viral load during pregnancy and breastfeeding period is the risk factor for vertical transmission of human immunodeficiency virus (HIV). Currently, Dolutegravir (DTG)-based regimens are recommended to attain adequate viral load suppression (VLS) among women. However, its effect on VLS has not been investigated among women in PMTCT care in Ethiopia.
No takes yet. Share an insight, caveat, or question.
Facha et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: